pharma
publication date
Pharma
Civica Rx to Supply California's $30 Insulin
CalRx will offer biosimilars for Glargine, Aspart, and Lispro, which are expected to be interchangeable with Lantus, Humalog, and Novolog...
Pharma
Lilly Slashes Insulin Prices by 70%. Will Novo Nordisk, Sanofi Follow?
Lilly's announcement puts pressure to follow suit on competitors Novo Nordisk and Sanofi.
Pharma
Senate Casts Skeptical Eye on PBMs: 'I Don't Know Why the Hell They Even Exist.'
The Senate Commerce Committee voiced bipartisan support for a bill to regulate PBMs.
Payer
'We Ain't Gonna Get It': Why Bernie Sanders Says His 'Medicare for All' Dream Must Wait
The Vermont Senator spoke with KHN about the prospects for lowering drug prices, expanding access to primary care, and 'Medicare...
Pharma
Biden's SOTU Bully Pulpit Flays Pharma
President raps 'record profits' from insulin sales; pushes $35 universal cap.
Pharma
Senate Presses CMS for Updates on Pharma Price-Gouging Penalties
The IRA provisions took effect for Medicare Part B drugs on October 1, 2022, and for Part D drugs on...
Pharma
Bipartisan Senate Bill Aims to Curb Drug Patent Abuse
The bill 'puts an end to practices that prioritize profits for pharmaceutical companies ahead of Americans' health.'
Pharma
Peptilogics CEO Jonathan Steckbeck Targets Deadly Prosthetic Infections
Personal tragedies involving family and friends motivated this CEO to launch Peptilogics.
Pharma
CA AG Sues Insulin Makers, PBMs for Price Gouging
Eli Lilly, Novo Nordisk, Sanofi, CVS Caremark, Express Scripts, and OptumRx are accused of overcharging patients.
Pharma
HHS Sets Key Dates for Medicare Drug Price Negotiations
Lowering the cost of prescription drugs is a key component of the Inflation Reduction Act.
Pharma
Amgen Pressed for 'Voluntary Compliance' in Senate Pharma Tax Avoidance Probe
Lawmakers are examining strategies drugmakers use to shield billions of dollars in profits from U.S. corporate taxes.
Payer
Paxlovid has been free so far. Next year, sticker shock awaits.
The U.S. government has so far purchased 20 million courses of Paxlovid, priced at about $530 each.